NCT03713359View on ClinicalTrials.gov

Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)

PHASE3CompletedINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
Signs and Symptoms
Interventions
BIOLOGICAL

Trial arm (MRVAC)

Volunteers from 1-45 years old will be injected only one dose of MRVAC vaccine

BIOLOGICAL

Control arm

Volunteers from 1-45 years old will be injected only one dose of MRVAC vaccine

All Listed Sponsors
collaborator

Vietnam Military Medical University

OTHER

lead

Center for Research and Production of Vaccines and Biologicals, Vietnam

OTHER_GOV

NCT03713359 - Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III) | Biotech Hunter | Biotech Hunter